Study of BioAegis’ lead product, Gelsolin, key component of NIAID strategic plan for COVID-19 research
On May 21, 2020, BioAegis Therapeutics announced that the National Institute of Health Clinical Center began measuring patient…
On May 21, 2020, BioAegis Therapeutics announced that the National Institute of Health Clinical Center began measuring patient…
On May 21, 2020, Montefiore Health System and Albert Einstein College of Medicine were the first sites in…
On May 20, 2020, Rapid Micro Biosystems announced a $120 million financing round, led by equity investment from…
On May 20, 2020, Airway Therapeutics and Celonic Group announced a collaboration to produce the novel human recombinant…
On May 20, 2020, INOVIO announced the publication of the preclinical study data for IN0-4800, its COVID-19 DNA…
On May 20, 2020, Bharat Biotech and Thomas Jefferson University of Philadelphia announced an exclusive deal to develop…
On May 20, 2020, ARENSIA announced an agreement with Diffusion Pharmaceuticals to begin a clinical trial program to test…
On May 20, 2020, Atossa Therapeutics announced the successful results from in vitro testing of AT-H201, Atossa’s proprietary COVID-19 drug…
On May 20, 2020, Mammoth Biosciences announced a collaboration with GSK Consumer Healthcare to develop an accurate, easy-to-use,…
On May 20, 2020, BioSig Technologies and its subsidiary, ViralClear Pharmaceuticals, announced the closing of a $10.8 million…
On May 19, 2020, the National Institutes of Health (NIH) reported that researchers from the University of Texas,…
On May 19, 2020, a University of Southern California (USC) study reported results from the first phase of…
On May 19, 2020, in a study published in Cell Reports, researchers at the University of Hong Kong…
On May 19, 2020, Oragenics announced, that through its wholly-owned subsidiary, Noachis Terra, it has entered into an…
On May 19, 2020, Innovation Pharma announced that its anti-SARS-CoV-2 (COVID-19) drug candidate, Brilacidin, in an in vitro…
On May 19, 2020, Bio-Techne and the Mount Sinai Health System in New York, through its commercial affiliate…
On May 19, 2020, Roche announced its Elecsys Anti-SARS-CoV-2 antibody test is live at more than 20 commercial…
On May 19, 2020, the Albert Einstein College of Medicine reported that while most children infected with the…
On May 19, 2020, Phlow, a U.S.-based, public benefit drug manufacturing corporation, received federal government funding of $354…
On May 19, 2020, CytoDyn announced it will be coordinating with the National Institution of Health of Mexico…
On May 18, 2020, NantKwest, now part of ImmunityBio, announced it had received authorization from the U.S. Food…
On May 18, 2020, Quidel announced it had received Emergency Use Authorization (EUA) for the Lyra Direct SARS-CoV-2…
On May 18, 2020, BioSig Technologies and its subsidiary, ViralClear Pharmaceuticals, announced the U.S. Food and Drug Administration…
On May 18, 2020, Todos Medical announced its first commercial sale of COVID-19 tests. The sale was made…
On May 18, 2020, the National Institutes of Health (NIH) reported that roughly 3 to 5% of children…
On May 18, 2020, an investigational long-acting form of the HIV drug cabotegravir injected once every 8 weeks…
On May 18, 2020, with $9 million from the COVID-19 Therapeutics Accelerator, an international group of physicians and…
On May 16, 2020, a single dose of ChAdOx1 nCoV-19, an investigational vaccine against SARS-CoV-2, has protected six…
On May 15, 2020, Duke-NUS Medical School, GenScript Biotech, and the Diagnostics Development Hub at Singapore’s Agency for…
On May 15, 2020, the California Institute for Regenerative Medicine (CIRM) board approved new clinical trials for COVID-19…